{"id":"https://openalex.org/W1987246352","doi":"https://doi.org/10.3389/fimmu.2014.00206","title":"Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1","display_name":"Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-16","ids":{"openalex":"https://openalex.org/W1987246352","doi":"https://doi.org/10.3389/fimmu.2014.00206","mag":"1987246352","pmid":"https://pubmed.ncbi.nlm.nih.gov/24904570","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4032988"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2014.00206","doi":"https://doi.org/10.3389/fimmu.2014.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2014.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2014.00206/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1987246352"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2014.00206/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109939211","display_name":"Yi-chi M. Kong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yi-chi M. Kong","raw_affiliation_strings":["Department of Immunology and Microbiology, Wayne State University School of Medicine , Detroit, MI , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Microbiology, Wayne State University School of Medicine , Detroit, MI , USA","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023278279","display_name":"Jeffrey C. Flynn","orcid":"https://orcid.org/0000-0003-2445-363X","observed_orcids":["https://orcid.org/0000-0003-2445-363X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey C. Flynn","raw_affiliation_strings":["Department of Orthopaedic Surgery, Providence Hospital and Medical Centers , Southfield, MI , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Orthopaedic Surgery, Providence Hospital and Medical Centers , Southfield, MI , USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109939211"],"corresponding_institution_ids":["https://openalex.org/I185443292"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.396,"has_fulltext":true,"cited_by_count":135,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92238131,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"5","issue":null,"first_page":"206","last_page":"206"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8450000286102295},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9819999933242798},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9620000123977661},{"id":"https://openalex.org/keywords/thyroid-autoimmunity","display_name":"thyroid autoimmunity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.968999981880188},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7329999804496765},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.527999997138977},{"id":"https://openalex.org/keywords/tumor-specific-immunity","display_name":"tumor-specific immunity","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9134718179702759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8047689199447632},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.7838107347488403},{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.6023805141448975},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5931384563446045},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5662197470664978},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.5445610880851746},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5032462477684021},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4898233115673065},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.44847768545150757},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.44548478722572327},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.434770405292511},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.42681336402893066},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35797467827796936},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.31939956545829773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2474011778831482},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07090911269187927}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2014.00206","doi":"https://doi.org/10.3389/fimmu.2014.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2014.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2014.00206/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3021500","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4032988","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4032988","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4032988/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:24904570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24904570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:405dc773469a42768350e33a8206053c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/405dc773469a42768350e33a8206053c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 5 (2014)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2014.00206","doi":"https://doi.org/10.3389/fimmu.2014.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2014.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2014.00206/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1987246352.pdf","grobid_xml":"https://content.openalex.org/works/W1987246352.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W193516638","https://openalex.org/W1504403518","https://openalex.org/W1620778402","https://openalex.org/W1969059327","https://openalex.org/W1974809655","https://openalex.org/W1986480205","https://openalex.org/W1994815971","https://openalex.org/W1997714882","https://openalex.org/W1999948487","https://openalex.org/W2002566731","https://openalex.org/W2002673340","https://openalex.org/W2009501181","https://openalex.org/W2011432214","https://openalex.org/W2014738741","https://openalex.org/W2015085911","https://openalex.org/W2016193783","https://openalex.org/W2016789384","https://openalex.org/W2017830847","https://openalex.org/W2021218996","https://openalex.org/W2022073464","https://openalex.org/W2033672531","https://openalex.org/W2045769493","https://openalex.org/W2046834643","https://openalex.org/W2049126749","https://openalex.org/W2056535502","https://openalex.org/W2061071534","https://openalex.org/W2069592230","https://openalex.org/W2071716344","https://openalex.org/W2072853625","https://openalex.org/W2076067786","https://openalex.org/W2082825884","https://openalex.org/W2082830752","https://openalex.org/W2085172491","https://openalex.org/W2086503910","https://openalex.org/W2094366129","https://openalex.org/W2097560051","https://openalex.org/W2097995306","https://openalex.org/W2099460562","https://openalex.org/W2099560139","https://openalex.org/W2101653483","https://openalex.org/W2101990345","https://openalex.org/W2102143045","https://openalex.org/W2102458026","https://openalex.org/W2107150019","https://openalex.org/W2107484016","https://openalex.org/W2107752337","https://openalex.org/W2108604103","https://openalex.org/W2109465910","https://openalex.org/W2109653150","https://openalex.org/W2109936982","https://openalex.org/W2111877246","https://openalex.org/W2112601576","https://openalex.org/W2115918781","https://openalex.org/W2118982164","https://openalex.org/W2119896120","https://openalex.org/W2121080857","https://openalex.org/W2124253294","https://openalex.org/W2124463063","https://openalex.org/W2126065508","https://openalex.org/W2126932404","https://openalex.org/W2128867995","https://openalex.org/W2136746908","https://openalex.org/W2139191751","https://openalex.org/W2140419562","https://openalex.org/W2140521865","https://openalex.org/W2143101384","https://openalex.org/W2143163879","https://openalex.org/W2144943759","https://openalex.org/W2145308813","https://openalex.org/W2150640296","https://openalex.org/W2152155935","https://openalex.org/W2158840473","https://openalex.org/W2160834915","https://openalex.org/W2162646864","https://openalex.org/W2162856391","https://openalex.org/W2163621501","https://openalex.org/W2166626276","https://openalex.org/W2172131454","https://openalex.org/W4211123988","https://openalex.org/W4249740009"],"related_works":["https://openalex.org/W2468949661","https://openalex.org/W2100274893","https://openalex.org/W7212192915","https://openalex.org/W2002566731","https://openalex.org/W2793232168","https://openalex.org/W2963849817","https://openalex.org/W2912377255","https://openalex.org/W3015082801","https://openalex.org/W4318407541","https://openalex.org/W2945421576"],"abstract_inverted_index":{"To":[0,114,146],"improve":[1],"the":[2,24,35,79,94,163],"efficacy":[3],"of":[4,31,104,142],"immunotherapy":[5],"for":[6],"cancer":[7],"and":[8,13,33,45,50,56,78,122,168],"autoimmune":[9,57,144],"diseases,":[10],"recent":[11],"ongoing":[12],"completed":[14],"clinical":[15,83,127,148],"trials":[16,84,128],"have":[17,151],"focused":[18],"on":[19,75],"specific":[20],"targets":[21],"to":[22,65,96,157,161],"redirect":[23],"immune":[25],"network":[26],"toward":[27],"eradicating":[28],"a":[29,39],"variety":[30],"tumors":[32],"ameliorating":[34],"self-destructive":[36],"process.":[37],"In":[38],"previous":[40],"review,":[41],"both":[42],"systemic":[43],"immunomodulators":[44],"monoclonal":[46],"antibodies":[47],"(mAbs),":[48],"anti-CTLA-4,":[49],"anti-CD52,":[51],"were":[52],"discussed":[53],"regarding":[54],"therapeutics":[55],"sequelae,":[58],"as":[59,61,90,129],"well":[60],"predisposing":[62],"factors":[63],"known":[64],"exacerbate":[66],"immune-related":[67],"adverse":[68],"events":[69],"(irAEs).":[70],"This":[71],"review":[72],"will":[73],"focus":[74],"immune-checkpoint":[76],"inhibitors,":[77],"data":[80],"from":[81],"most":[82],"involve":[85],"blockade":[86],"with":[87,100,134],"anti-CTLA-4":[88],"such":[89],"ipilimumab.":[91],"However,":[92],"despite":[93],"mild":[95],"severe":[97],"irAEs":[98],"observed":[99],"ipilimumab":[101],"in":[102],"~60%":[103],"patients,":[105],"overall":[106],"survival":[107],"(OS)":[108],"averaged":[109],"~22-25%":[110],"at":[111],"3-5":[112],"years.":[113],"boost":[115],"OS,":[116],"other":[117],"mAbs":[118],"targeting":[119],"programed":[120],"death-1":[121],"its":[123],"ligand":[124],"are":[125],"undergoing":[126],"monotherapy":[130],"or":[131],"dual":[132],"therapy":[133],"anti-CTLA-4.":[135],"Therapeutic":[136],"combinations":[137],"may":[138],"generate":[139],"different":[140],"spectrum":[141],"opportunistic":[143],"disorders.":[145],"simulate":[147],"scenarios,":[149],"we":[150],"applied":[152],"regulatory":[153],"T":[154],"cell":[155],"perturbation":[156],"murine":[158],"models":[159],"combined":[160],"examine":[162],"balance":[164],"between":[165],"thyroid":[166],"autoimmunity":[167],"tumor-specific":[169],"immunity.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1987246352","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
